SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-14-448688
Filing Date
2014-12-19
Accepted
2014-12-19 16:31:34
Documents
1
Group Members
AGTC ADVISORS FUND, L.P.AGTC PARTNERS, L.P.APPLIED GENOMIC TECHNOLOGY CAPITAL FUND L.P.EDWIN M. KANIA, JR.FLAGSHIP VENTURES 2007 GENERAL PARTNER, LLCFLAGSHIP VENTURES FUND 2007, L.P.FLAGSHIP VENTURES MANAGEMENT, INC.NEWCOGEN EQUITY INVESTORS LLCNEWCOGEN G

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d839918dsc13da.htm SC 13D/A 276599
  Complete submission text file 0001193125-14-448688.txt   278593
Mailing Address ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
NEWCOGEN GROUP LLC (Filed by) CIK: 0001097548 (see all company filings)

IRS No.: 043480904
Type: SC 13D/A

Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Subject) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86104 | Film No.: 141300008
SIC: 2835 In Vitro & In Vivo Diagnostic Substances